Studies long-term side effects of bladder cancer treatment on quality of life
Observes how late side effects of bladder cancer treatment affect quality of life in adults.
Plain-language title generated from the registry record
Registry title: The Impact of Late Effects After Treatment for Bladder Cancer on Quality of Life
Key facts
- Where
- Aarhus N, Gødstrup, Horsens, Randers, and Viborg, DenmarkSee the 5 sites
Where in Denmark
- Department of Urology Aarhus University HospitalAarhus N, DenmarkNo longer taking part
- Department of Urology, Regional Hospital GødstrupGødstrup, DenmarkNo longer taking part
- Department of Urology, Regional Hospital HorsensHorsens, DenmarkNo longer taking part
- Department of Urology, Regional Hospital RandersRanders, DenmarkNo longer taking part
- Department of Urology, Regional Hospital ViborgViborg, DenmarkNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Aarhus University Hospital
- Trial code
- NCT05195515
- Record updated
- 3 March 2026
- Original description
Bladder Cancer prognosis, treatment, and subsequent morbidity and mortality vary between the different stages, thus resulting in a different impact on patients' lives. There are some well known late effects of the treatments for bladder cancer, but the knowledge of their impact on patients Quality of Life is sparse. This study aims to determine the prevalence of late effects impact on Quality of Life and potential risk factors for impairment.Read full original descriptionShow less
The Impact of Late Effects After Treatment for Bladder Cancer on Quality of Life - What is the Cost of the Cure?
Bladder Cancer prognosis, treatment, and subsequent morbidity and mortality vary between the different stages, thus resulting in a different impact on patients' lives. There are some well known late effects of the treatments for bladder cancer, but the knowledge of their impact on patients Quality of Life is sparse. This study aims to determine the prevalence of late effects impact on Quality of Life and potential risk factors for impairment.
Inclusion: Patients are eligible if they are referred to a hospital in the Central Region Denmark, due to hematuria between 01/01/2022 and 01/01/2023; Ability to understand written and oral Danish.
Exclusion: Known Alzheimers disease; Diagnosed other causes explaining the hematuria.